Small Cell Lung Cancer Extensive Stage Clinical Trials in Portland, Oregon
2 recruitingPortland, Oregon
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
Small Cell Lung Cancer Extensive Stage
Merck Sharp & Dohme LLC170 enrolled31 locationsNCT07227597
Recruiting
Phase 1Phase 2
Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC Patients
Small Cell Lung Cancer Extensive Stage
Genprex, Inc.62 enrolled17 locationsNCT05703971